Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1391
| Despition | Apolipoprotein-D Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95% (SDS-PAGE) |
| Form | Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1333 | Nurr1 Blocking Peptide (AC1333) | 250 µg | inquiry |
| ACPP-1735 | Human BEST1 Protein (AC1735) | 5 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1560 | Human RBM17 Protein (AC1560) | 2 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1840 | Human ALDH1A1 Protein (AC1840) | 5 µg | inquiry |
| ACPP-1090 | PAX5 Blocking Peptide (AC1090) | 250 µg | inquiry |
| ACPP-1005 | Recombinant Human CNTF Protein (AC1005) | 50 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.